Spero Therapeutics (SPRO) Other Accumulated Expenses (2016 - 2025)
Historic Other Accumulated Expenses for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to $82000.0.
- Spero Therapeutics' Other Accumulated Expenses fell 5684.21% to $82000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $82000.0, marking a year-over-year decrease of 5684.21%. This contributed to the annual value of $120000.0 for FY2024, which is 4915.25% down from last year.
- Spero Therapeutics' Other Accumulated Expenses amounted to $82000.0 in Q3 2025, which was down 5684.21% from $89000.0 recorded in Q2 2025.
- Spero Therapeutics' Other Accumulated Expenses' 5-year high stood at $1.3 million during Q3 2021, with a 5-year trough of $82000.0 in Q3 2025.
- For the 5-year period, Spero Therapeutics' Other Accumulated Expenses averaged around $404842.1, with its median value being $208000.0 (2024).
- Per our database at Business Quant, Spero Therapeutics' Other Accumulated Expenses soared by 46824.64% in 2023 and then crashed by 8415.35% in 2024.
- Over the past 5 years, Spero Therapeutics' Other Accumulated Expenses (Quarter) stood at $1.2 million in 2021, then plummeted by 83.17% to $209000.0 in 2022, then grew by 12.92% to $236000.0 in 2023, then tumbled by 49.15% to $120000.0 in 2024, then crashed by 31.67% to $82000.0 in 2025.
- Its Other Accumulated Expenses stands at $82000.0 for Q3 2025, versus $89000.0 for Q2 2025 and $102000.0 for Q1 2025.